Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value
$349.38−0.50 (-0.14%)
Close on Nov 12, 2026Market cap $66.67BP/E 25.9Yield 0.63%
Cencora total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cencora's total debt was $11.72B at Jun 30, 2026. For fiscal 2025 it was $7.66B, up 74.6% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $7.66B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.66B | +74.6% |
| FY2024 | Sep 30, 2024 | $4.39B | -8.3% |
| FY2023 | Sep 30, 2023 | $4.79B | -16.1% |
| FY2022 | Sep 30, 2022 | $5.70B | -14.7% |
| FY2021 | Sep 30, 2021 | $6.68B | +62.3% |
| FY2020 | Sep 30, 2020 | $4.12B | -1.3% |
| FY2019 | Sep 30, 2019 | $4.17B | -3.2% |
| FY2018 | Sep 30, 2018 | $4.31B | +25.2% |
| FY2017 | Sep 30, 2017 | $3.44B | -17.8% |
| FY2016 | Sep 30, 2016 | $4.19B | +19.9% |
| FY2015 | Sep 30, 2015 | $3.49B | +75.0% |
| FY2014 | Sep 30, 2014 | $2.00B | +42.9% |
| FY2013 | Sep 30, 2013 | $1.40B | +0.0% |
| FY2012 | Sep 30, 2012 | $1.40B | +2.3% |
| FY2011 | Sep 30, 2011 | $1.36B | +1.6% |
| FY2010 | Sep 30, 2010 | $1.34B | +14.1% |
| FY2009 | Sep 30, 2009 | $1.18B | -0.9% |
| FY2008 | Sep 30, 2008 | $1.19B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $11.72B | +42.3% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $12.39B | +57.7% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $7.92B | -2.8% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $7.66B | +74.6% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $8.24B | +74.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $7.86B | +49.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $8.15B | +70.5% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $4.39B | -8.3% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $4.73B | -5.8% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $5.25B | +6.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $4.78B | -15.3% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $4.79B | -16.1% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $5.02B | -17.2% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $4.93B | -23.6% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $5.64B | -15.5% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $5.70B | -14.7% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $6.06B | -14.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $6.46B | +4.3% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $6.68B | +80.6% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $6.68B | +62.3% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $7.10B | +71.6% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $6.19B | +49.4% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $3.70B | -11.2% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.12B | -1.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $4.14B | -1.1% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $4.15B | -3.4% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $4.17B | -3.5% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $4.17B | -3.2% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $4.18B | -4.8% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $4.29B | -5.3% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $4.32B | +0.8% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $4.31B | +25.2% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $4.39B | +28.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $4.53B | +10.7% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $4.29B | +3.7% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $3.44B | -17.8% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $3.43B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $4.09B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $4.14B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $4.19B | – |
See a number that looks wrong?